ACCURAY INC (ARAY) Fundamental Analysis & Valuation

NASDAQ:ARAY • US0043971052

Current stock price

0.4649 USD
+0.01 (+2.63%)
At close:
0.45 USD
-0.01 (-3.2%)
After Hours:

This ARAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ARAY Profitability Analysis

1.1 Basic Checks

  • In the past year ARAY has reported negative net income.
  • ARAY had a positive operating cash flow in the past year.
  • In the past 5 years ARAY always reported negative net income.
  • In multiple years ARAY reported negative operating cash flow during the last 5 years.
ARAY Yearly Net Income VS EBIT VS OCF VS FCFARAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • ARAY has a better Return On Assets (-7.95%) than 63.64% of its industry peers.
  • ARAY's Return On Equity of -66.68% is in line compared to the rest of the industry. ARAY outperforms 43.85% of its industry peers.
Industry RankSector Rank
ROA -7.95%
ROE -66.68%
ROIC N/A
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)N/A
ROIC(5y)N/A
ARAY Yearly ROA, ROE, ROICARAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • ARAY's Operating Margin has declined in the last couple of years.
  • ARAY has a worse Gross Margin (27.83%) than 75.94% of its industry peers.
  • In the last couple of years the Gross Margin of ARAY has declined.
  • The Profit Margin and Operating Margin are not available for ARAY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.83%
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
ARAY Yearly Profit, Operating, Gross MarginsARAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ARAY Health Analysis

2.1 Basic Checks

  • ARAY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ARAY has more shares outstanding
  • Compared to 5 years ago, ARAY has more shares outstanding
  • The debt/assets ratio for ARAY has been reduced compared to a year ago.
ARAY Yearly Shares OutstandingARAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ARAY Yearly Total Debt VS Total AssetsARAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -0.49, we must say that ARAY is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.49, ARAY perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
  • A Debt/Equity ratio of 2.34 is on the high side and indicates that ARAY has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.34, ARAY is not doing good in the industry: 85.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACCN/A
WACC6.9%
ARAY Yearly LT Debt VS Equity VS FCFARAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • ARAY has a Current Ratio of 1.47. This is a normal value and indicates that ARAY is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.47, ARAY is not doing good in the industry: 78.61% of the companies in the same industry are doing better.
  • ARAY has a Quick Ratio of 1.47. This is a bad value and indicates that ARAY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ARAY has a Quick ratio of 0.71. This is amonst the worse of the industry: ARAY underperforms 89.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.71
ARAY Yearly Current Assets VS Current LiabilitesARAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ARAY Growth Analysis

3.1 Past

  • The earnings per share for ARAY have decreased strongly by -418.00% in the last year.
  • ARAY shows a decrease in Revenue. In the last year, the revenue decreased by -3.57%.
  • The Revenue has been growing slightly by 3.67% on average over the past years.
EPS 1Y (TTM)-418%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
Revenue 1Y (TTM)-3.57%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-11.99%

3.2 Future

  • ARAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 83.91% yearly.
  • Based on estimates for the next years, ARAY will show a small growth in Revenue. The Revenue will grow by 2.02% on average per year.
EPS Next Y-902.41%
EPS Next 2Y-92.17%
EPS Next 3Y83.91%
EPS Next 5YN/A
Revenue Next Year-2.54%
Revenue Next 2Y0.96%
Revenue Next 3Y2.02%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARAY Yearly Revenue VS EstimatesARAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
ARAY Yearly EPS VS EstimatesARAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. ARAY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ARAY. In the last year negative earnings were reported.
  • Also next year ARAY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARAY Price Earnings VS Forward Price EarningsARAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARAY Per share dataARAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ARAY's earnings are expected to grow with 83.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-92.17%
EPS Next 3Y83.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARAY Dividend Analysis

5.1 Amount

  • ARAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARAY Fundamentals: All Metrics, Ratios and Statistics

ACCURAY INC

NASDAQ:ARAY (4/24/2026, 7:19:48 PM)

After market: 0.45 -0.01 (-3.2%)

0.4649

+0.01 (+2.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)05-06
Inst Owners70.88%
Inst Owner Change0%
Ins Owners3.75%
Ins Owner Change17.07%
Market Cap55.22M
Revenue(TTM)436.97M
Net Income(TTM)-35.62M
Analysts87.5
Price Target2.58 (454.96%)
Short Float %6.7%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-63.4%
Min EPS beat(2)-128.76%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-35.2%
Min EPS beat(4)-128.76%
Max EPS beat(4)80.39%
EPS beat(8)5
Avg EPS beat(8)-37.59%
EPS beat(12)7
Avg EPS beat(12)-47.14%
EPS beat(16)10
Avg EPS beat(16)-37.27%
Revenue beat(2)1
Avg Revenue beat(2)0.1%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)0.82%
Revenue beat(4)3
Avg Revenue beat(4)2.65%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)9.35%
Revenue beat(8)6
Avg Revenue beat(8)1.43%
Revenue beat(12)8
Avg Revenue beat(12)1.25%
Revenue beat(16)10
Avg Revenue beat(16)0.89%
PT rev (1m)0%
PT rev (3m)-34.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-125%
EPS NY rev (1m)0%
EPS NY rev (3m)-14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF 12.14
P/B 1.03
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.04
OCFY8.23%
SpS3.68
BVpS0.45
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -7.95%
ROE -66.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.83%
FCFM N/A
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.6%
ROCE(5y)3.12%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.78%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.71
Altman-Z -0.49
F-Score4
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)136.79%
Cap/Depr(5y)106.47%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-418%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
EPS Next Y-902.41%
EPS Next 2Y-92.17%
EPS Next 3Y83.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.57%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-11.99%
Revenue Next Year-2.54%
Revenue Next 2Y0.96%
Revenue Next 3Y2.02%
Revenue Next 5YN/A
EBIT growth 1Y-281.24%
EBIT growth 3Y-1.09%
EBIT growth 5Y-8.91%
EBIT Next Year181.28%
EBIT Next 3Y102.89%
EBIT Next 5YN/A
FCF growth 1Y-134.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.07%
OCF growth 3YN/A
OCF growth 5YN/A

ACCURAY INC / ARAY Fundamental Analysis FAQ

What is the fundamental rating for ARAY stock?

ChartMill assigns a fundamental rating of 1 / 10 to ARAY.


Can you provide the valuation status for ACCURAY INC?

ChartMill assigns a valuation rating of 1 / 10 to ACCURAY INC (ARAY). This can be considered as Overvalued.


Can you provide the profitability details for ACCURAY INC?

ACCURAY INC (ARAY) has a profitability rating of 1 / 10.


What is the expected EPS growth for ACCURAY INC (ARAY) stock?

The Earnings per Share (EPS) of ACCURAY INC (ARAY) is expected to decline by -902.41% in the next year.